Evgen Pharma is focused on the clinical development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases.
Evgen Pharma asked us to help them with their 2022 Annual Report based on what they’d seen us produce for some of our other clients.
Working closely with their team we helped to develop and restructure the annual report, helping to strengthen their story and key messages.
The result gave the report more focus and clarity on their strategy.